TheDiArc Exclusive

The DiArc Magazine November 2022 Edition by Christina DiArcangelo

An exclusive magazine by Christina DiArcangelo describing the role of women and business around the world.

Zelira Therapeutics Completes Enrolment For Diabetic Nerve Pain Drug Trial With Affinity Bio Partners

It’s an exciting time in the medical cannabis community as Zelira, a global leader in the research, development and commercialisation of clinically validated cannabinoid medicines, and Affinity Bio Partners, a leading, global clinical research organisation, have completed enrolment for a diabetic nerve pain drug trial.

Is Cannabidiol Oil or CBD Oil Helpful for Anxiety? TheDiArc.Com

Cannabidiol is defined as a chemical present in the...

Christina DiArcangelo as Keynote speaker in Boston for Oncology Conference

Christina DiArcangelo had the recent pleasure of being invited to speak this month in Boston at an Oncology Conference hosted by Arena entitled as:

CLINICAL OPERATIONS IN ONCOLOGY TRIALS EAST COAST 2022

Christina DiArcangelo was requested to speak about the need within the traditional Pharmaceutical industry to work with patient advocacy groups like her, Affinity Patient Advocacy.  

CD was honored to discuss her journey of being her father, Albert J DiArcangelo, Sr.’s patient advocate when he was dying of Stage 4 Liver, Lung and Stomach cancers. This journey was very eye opening for CD as that is the sole reason why she started Affinity Patient Advocacy.  

Christina described her father’s last day of his life and some of the missteps with his medical care and treatment. Coordinating medical treatments, asking the right questions, mitigating risk, and trying to understand everything that is going on with your loved one is not an easy process.  Patients and their families need support.

In CD’s humble opinion, the traditional pharmaceutical industry is not proactively accessing patient advocacy firms. The patient advocates are the people that truly understand the patient’s therapeutic issues, and develops a relationship with the patient from the beginning.  The patient advocates have  the ability to share with the pharmaceutical company information and data that they are receiving directly from the type of patients that the pharmaceutical company is trying to recruit. 

It is time for the pharmaceutical industry to do better, be better and rise up to truly learning what the patients need. The patients deserve better. 

Christina DiArcangelo – Keynote Speaker | Boston Conference

Christina DiArcangelo – “CLINICAL OPERATIONS IN ONCOLOGY TRIALS EAST COAST 2022”

I had the recent pleasure of being invited to speak this month in Boston at an Oncology Conference hosted by Arena entitled.

I was requested to speak about the need within the traditional Pharmaceutical industry to work with patient advocacy groups like mine, Affinity Patient Advocacy.  

I was honored to discuss my journey of being my father, Albert J DiArcangelo, Sr.’s patient advocate when he was dying of Stage 4 Liver, Lung and Stomach cancers. This journey was very eye opening for me as that is the sole reason why I started Affinity Patient Advocacy.  

I described my father’s last day of his life and some of the missteps with his medical care and treatment.  Coordinating medical treatments, asking the right questions, mitigating risk, and trying to understand everything that is going on with your loved one is not an easy process.  Patients and their families need support.

In my humble opinion, the traditional pharmaceutical industry is not proactively accessing patient advocacy firms.  The patient advocates are the people that truly understand the patient’s therapeutic issues, and develops a relationship with the patient from the beginning.  The patient advocates have  the ability to share with the pharmaceutical company information and data that they are receiving directly from the type of patients that the pharmaceutical company is trying to recruit. 

It is time for the pharmaceutical industry to do better, be better and rise up to truly learning what the patients need. The patients deserve better. 

Christina DiArcangelo 

Latest

Zelira Therapeutics Completes Enrolment For Diabetic Nerve Pain Drug Trial With Affinity Bio Partners

It’s an exciting time in the medical cannabis community as Zelira, a global leader in the research, development and commercialisation of clinically validated cannabinoid medicines, and Affinity Bio Partners, a leading, global clinical research organisation, have completed enrolment for a diabetic nerve pain drug trial.

CANNABIS – The Revival of an Ancient Women’s Herb With Shabnam

Cannabis - the revival of an ancient women's herb From Egyptian antiquity to the fifteenth century, women relied on a vast knowledge of medicinal plants for their health. Herbal formulations for regulating their fertility, facilitating childbirth, and  intensifying orgasm, to name a few!

Listen to your Gut with Chelsea Haines

My name is Chelsea Haines, I am the founder and CEO of the Gut Health Agency. I have  years of accolades that warrant me credit to share what I’m about to share with you regarding human behaviour and gut health

How did stigmatised housewife make it on the NJ Insider 100?

DiAnA was the Community Outreach Specialist for one of the Original 12 license holders a vertically integrated MSO in New Jersey.

Newsletter

Don't miss

Zelira Therapeutics Completes Enrolment For Diabetic Nerve Pain Drug Trial With Affinity Bio Partners

It’s an exciting time in the medical cannabis community as Zelira, a global leader in the research, development and commercialisation of clinically validated cannabinoid medicines, and Affinity Bio Partners, a leading, global clinical research organisation, have completed enrolment for a diabetic nerve pain drug trial.

CANNABIS – The Revival of an Ancient Women’s Herb With Shabnam

Cannabis - the revival of an ancient women's herb From Egyptian antiquity to the fifteenth century, women relied on a vast knowledge of medicinal plants for their health. Herbal formulations for regulating their fertility, facilitating childbirth, and  intensifying orgasm, to name a few!

Listen to your Gut with Chelsea Haines

My name is Chelsea Haines, I am the founder and CEO of the Gut Health Agency. I have  years of accolades that warrant me credit to share what I’m about to share with you regarding human behaviour and gut health

How did stigmatised housewife make it on the NJ Insider 100?

DiAnA was the Community Outreach Specialist for one of the Original 12 license holders a vertically integrated MSO in New Jersey.

The DiArc December 2022 Edition Exclusive Magazine By Christina DiArcangelo

TheDiArc Magazine December 2022 Edition has been published. In this edition we are bringing the best articles as always. You will get to know more about Christina DiArcangelo and her daily routine. In Fitness section, we are trying to make people more aware of their GUT Health with Chelsea Haines
Christina DiArcangelo
Christina DiArcangelohttp://www.christinadiarcangelo.com
Christina DiArcangelo has forged a world-class reputation in the Biotechnology and Pharmaceutical industry for the past 22 years. Her engagements have led to numerous industry awards, keynote speaking engagements, TV and media appearances, a multitude of global clinical trials as well as working on several drugs that have received FDA approval and the ultimate respect of her industry peers. Throughout the course of Christina's career, she has acted in various capacities for Global Clinical Research Organizations, Pharmaceutical Companies and Biotechnology Companies.

Zelira Therapeutics Completes Enrolment For Diabetic Nerve Pain Drug Trial With Affinity Bio Partners

It’s an exciting time in the medical cannabis community as Zelira, a global leader in the research, development and commercialisation of clinically validated cannabinoid medicines, and Affinity Bio Partners, a leading, global clinical research organisation, have completed enrolment for a diabetic nerve pain drug trial.

CANNABIS – The Revival of an Ancient Women’s Herb With Shabnam

Cannabis - the revival of an ancient women's herb From Egyptian antiquity to the fifteenth century, women relied on a vast knowledge of medicinal plants for their health. Herbal formulations for regulating their fertility, facilitating childbirth, and  intensifying orgasm, to name a few!

Listen to your Gut with Chelsea Haines

My name is Chelsea Haines, I am the founder and CEO of the Gut Health Agency. I have  years of accolades that warrant me credit to share what I’m about to share with you regarding human behaviour and gut health